Outcome of Different Therapeutic Interventions in Mild COVID-19 Infection

Journal Title: Journal of Clinical Immunology & Microbiology - Year 2021, Vol 2, Issue 2

Abstract

Background: Coronavirus disease 2019 (COVID-19) case and the death toll has reached milestones of over 12,28,22,505 and 27,09,041 respectively worldwide as of 22nd March 2021. Treatment regimens are cropping up daily and adding up to the dilemma of the treating physicians. Aims: This present study aimed to see the Clinical Response of Well-Being (CRWB) reporting time in mild COVID-19 infected patients after their treatment initiation in four different treatment arms. Methods: A total of 56 patients meeting the case definition of mild COVID-19 infection were included after the retrospective screening of the investigators’ electronic database. Patients were divided into four groups - Hydroxychloroquine (HCQ) taking group, patients on the combination of Doxycycline (DOX) + Ivermectin (IVR), Azithromycin (AZ) taking group and symptomatic treatment receiving group. Results: There was no difference in CRWB between the four groups (p-value 0.846). The group on symptomatic management arm showed significant correlation between CRP (p-value 0.01), LDH (p-value 0.001), and age (p-value 0.035) with CRWB. Significant correlation was also seen between blood levels of CRP (p-value 0.03), LDH (p-value 0.001) and D-dimer (p-value 0.04) with CRWB in the IVR+DOX group. Conclusion: No specific drug treatment is required to treat mild COVID-19 infection other than symptomatic management in patients with a low risk of progression.

Authors and Affiliations

Sayak Roy*, Shambo Samrat Samajdar, Santanu K Tripathi, Shatavisa Mukherjee, Kingshuk Bhattacharjee

Keywords

Related Articles

Limited Temporary Effect of Several Social Relaxation Events on the COVID-19 Series: An Analysis Based on Primary Data

The relaxation of restrictive measures imposed by the COVID-19 pandemic allowed a gradual resumption of human activities, although the influence of each measure on the COVID-19 series is not consensual. We analyzed the...

Deforestation, Air Pollution and Brazilian COVID-19 Variant

Aim of this work is to submit to the researcher the relationship whit climate condition, air pollution and deforestation in Manaus zone in Brazil and the rapid spread of so called Brazilian COVID-19 variant. Also othe...

Repurposing Donepezil to Treat COVID-19: A Call for Retrospective Analysis of Existing Patient Datasets

We hypothesize that patients treated with donepezil will show decreased risk of death following COVID-19 infection. The acetylcholinesterase antagonist donepezil is widely prescribed for early-stage Alzheimer’s disease...

Review on Cancer and the Immune System

Cancer is a term for a large group of diseases caused by abnormal cells divide rapidly and spread to other tissue and organs. Under normal circumstances, so many cells multiply as long as the body is in need of them for...

COVID-19 Epidemics Monitored Through the Logarithmic Growth Rate and SIR Model

The SIR model is often used to analyse and forecast an epidemic. In this model, the number of patients exponentially increases and decreases in the early and late phases; hence the logarithmic growth rate K is constant a...

Download PDF file
  • EP ID EP699100
  • DOI http://dx.doi.org/10.46889/JCIM.2021.2203
  • Views 89
  • Downloads 0

How To Cite

Sayak Roy*, Shambo Samrat Samajdar, Santanu K Tripathi, Shatavisa Mukherjee, Kingshuk Bhattacharjee (2021). Outcome of Different Therapeutic Interventions in Mild COVID-19 Infection. Journal of Clinical Immunology & Microbiology, 2(2), -. https://europub.co.uk/articles/-A-699100